Application 207754
- Type
- ANDA
- Sponsor
- GLENMARK PHARMS INC
Application Products#
Product, Drug, Ingredient table| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|
| 001 | FULVESTRANT | FULVESTRANT | INJECTABLE;INTRAMUSCULAR | 50MG/ML | No | No |
NDC Listings For This Application#
NDC, Name, Nonproprietary name table| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|
| 68001-510 | Fulvestrant | Fulvestrant | BluePoint Laboratories | ANDA | Current |
| 68001-510 | Fulvestrant | Fulvestrant | BluePoint Laboratories | ANDA | Current |
| 68462-317 | Fulvestrant | Fulvestrant | GLENMARK PHARMACEUTICALS INC., USA | ANDA | Current |
| 68462-317 | Fulvestrant | Fulvestrant | GLENMARK PHARMACEUTICALS INC., USA | ANDA | Current |
| 68462-317 | Fulvestrant | Fulvestrant | GLENMARK PHARMACEUTICALS INC., USA | ANDA | Current |
| 68462-317 | Fulvestrant | Fulvestrant | GLENMARK PHARMACEUTICALS INC., USA | ANDA | Current |
| 68462-317 | Fulvestrant | Fulvestrant | GLENMARK PHARMACEUTICALS INC., USA | ANDA | Current |
| 68462-317 | Fulvestrant | Fulvestrant | GLENMARK PHARMACEUTICALS INC., USA | ANDA | Current |